Advanced Oncotherapy #AVO – Exclusive distribution agreement for China and other geographies & new equity investments for a total consideration of £37m

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has signed an exclusive distribution agreement with Yantai CIPU Medical Technology Co. Ltd. to market and sell Advanced Oncotherapy’s LIGHT system across China, Macau, Taiwan, Hong-Kong and South Korea. Under the agreement, Yantai CIPU will make a payment of £16.5 […]

Advanced Oncotherapy (AVO) – Interim results announcement

Advanced Oncotherapy (AIM: AVO), the developer of a next generation proton therapy system for cancer treatment, announces its unaudited results for the six months ended 30 June 2017 and post-period events.  Highlights: ·     Technological milestones reached with successful integration and testing of proton source, RFQ and SCDTL significantly de-risking development process ·     Progress at the Harley Street […]

Advanced Oncotherapy (AVO) – Financing facility provided by significant shareholders

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a consortium formed by AB Segulah and other investors has made available a £3.9m loan to the Company.  The loan will have a two year maturity and a 12% per annum rolled up interest rate.  The Segulah group includes AB Segulah, a […]

Advanced Oncotherapy (AVO) – Major Shareholder increases stake

NOTIFICATION OF MAJOR INTEREST IN SHARES  download movie War for the Planet of the Apes 2017 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Advanced Oncotherapy plc   2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal […]

Advanced Oncotherapy (AVO) – Significant Shareholder Dealing

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that AB Segulah, a significant shareholder of the Company, today purchased 150,000 ordinary shares of 25 pence each in the Company at a price of 66 pence per Ordinary Share. Following this transaction, AB Segulah now holds 3,219,451 Ordinary Shares representing […]